China CAS:51333-22-3 Manufacturer

August 2022
Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
99% manufactures meets the requirements of GMP.
Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

IPhEB Russia 2024 will be held at International Exhibition Centre“Crocus Expo”from November 19 to 22, our booth number is B9023.

CPHI Middle East 2024 will be held in Riyadh from 10 Dec 2024 - 12 Dec 2024. The pavilion is located at Riyadh Front Exhibition & Convention Center Riyadh and our booth number is 3.G43.

CPhI South East Asia 2025 will be held at MITEC, Kuala Lumpur, Malaysia from 16 Jul to 18 Jul 2025, our booth number is N33.

I've spent over twenty years working with companies like yours, and if there's one question I hear more than any other, it's this one. Selecting the right intermediates can feel like a high-stakes puzzle, where one wrong piece can impact your entire production line. It’s a decision that goes beyond mere cost; it's about partnership, reliability, and the integrity of your final product. In my journey, I've seen how a strategic partnership with a focused manufacturer like Humanwell Pharmaceutical can transform this challenging task from a source of anxiety into a competitive advantage. Let's break down the critical parameters you need to consider.

Finasteride is one of the most widely researched and prescribed medications for treating male pattern hair loss and benign prostatic hyperplasia (BPH). By targeting the hormonal pathways responsible for hair follicle miniaturization and prostate enlargement, Finasteride has become a cornerstone pharmaceutical ingredient in dermatology and urology. This in-depth guide explores how Finasteride works, its benefits, dosage, safety profile, side effects, comparisons with alternatives, and why global pharmaceutical manufacturers such as Humanwell play a crucial role in its production and supply.